Figures & data
Table I. Efflux mechanisms of antimicrobial resistancea.
Poole K. Efflux‐mediated antimicrobial resistance. J Antimicrob Chemother 2005; 56: 20–51 Truong‐Bolduc Q. C., Dunman P. M., Strahilevitz J., Projan S. J., Hooper D. C. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol 2005; 187: 2395–405 Truong‐Bolduc Q. C., Strahilevitz J., Hooper D. C. NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 1104–7 Ge B., McDermott P. F., White D. G., Meng J. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2005; 49: 3347–54 Gould V. C., Avison M. B. SmeDEF‐mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships. J Antimicrob Chemother 2006; 57: 1070–6 Pumbwe L., Chang A., Smith R. L., Wexler H. M. Clinical significance of overexpression of multiple RND‐family efflux pumps in Bacteroides fragilis isolates. J Antimicrob Chemother 2006; 58: 543–8 Oyamada Y., Ito H., Inoue M., Yamagishi J. Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis. J Med Microbiol 2006; 55: 1395–401 Ojo K. K., Ulep C., Van Kirk N., Luis H., Bernardo M., Leitao J., et al. The mef(A) gene predominates among seven macrolide resistance genes identified in gram‐negative strains representing 13 genera, isolated from healthy Portuguese children. Antimicrob Agents Chemother 2004; 48: 3451–6 Luna V. A., Cousin S., Jr., Whittington W. L., Roberts M. C. Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother 2000; 44: 2503–6 Rouquette‐Loughlin C. E., Balthazar J. T., Shafer W. M. Characterization of the MacA‐MacB efflux system in Neisseria gonorrhoeae. J Antimicrob Chemother 2005; 56: 856–60 Masuda N., Sakagawa E., Ohya S., Gotoh N., Tsujimoto H., Nishino T. Substrate specificities of MexAB‐OprM, MexCD‐OprJ, and MexXY‐OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000; 44: 3322–7 Chau S. L., Chu Y. W., Houang E. T. Novel resistance‐nodulation‐cell division efflux system AdeDE in Acinetobacter genomic DNA group 3. Antimicrob Agents Chemother 2004; 48: 4054–5 Mamelli L., Prouzet‐Mauleon V., Pages J. M., Megraud F., Bolla J. M. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother 2005; 56: 491–7 Giovanetti E., Brenciani A., Burioni R., Varaldo P. E. A novel efflux system in inducibly erythromycin‐resistant strains of Streptococcus pyogenes. Antimicrob Agents Chemother 2002; 46: 3750–5 Cagliero C., Mouline C., Payot S., Cloeckaert A. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli. J Antimicrob Chemother 2005; 56: 948–50 Hisanaga T., Hoban D. J., Zhanel G. G. Mechanisms of resistance to telithromycin in Streptococcus pneumoniae. J Antimicrob Chemother 2005; 56: 447–50 Canton R., Mazzariol A., Morosini M. I., Baquero F., Cornaglia G. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J Antimicrob Chemother 2005; 55: 489–95 Chollet R., Chevalier J., Bryskier A., Pages J. M. The AcrAB‐TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob Agents Chemother 2004; 48: 3621–4 Peleg A. Y., Potoski B. A., Rea R., Adams J., Sethi J., Capitano, et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 2007; 59: 128–131 Chang L. L., Chen H. F., Chang C. Y., Lee T. M., Wu W. J. Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 2004; 53: 518–21 Gil H., Platz G. J., Forestal C. A., Monfett M., Bakshi C. S., Sellati T. J., et al. Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci U S A 2006; 103: 12897–902 Schumacher A., Trittler R., Bohnert J. A., Kummerer K., Pages J. M., Kern W. V. Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J Antimicrob Chemother, in press Pumbwe L., Ueda O., Yoshimura F., Chang A., Smith R. L., Wexler H. M. Bacteroides fragilis BmeABC efflux systems additively confer intrinsic antimicrobial resistance. J Antimicrob Chemother 2006; 58: 37–46 van Amsterdam K., Bart A., van der E. A. A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother 2005; 49: 1477–82 Colangeli R., Helb D., Sridharan S., Sun J., Varma‐Basil M., Hazbon M. H., et al. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol Microbiol 2005; 55: 1829–40